United Therapeutics (UTHR) CEO exercises options, sells 9,500 shares
Rhea-AI Filing Summary
UNITED THERAPEUTICS Corp (UTHR) reported insider activity by Chairperson & CEO Martine A. Rothblatt involving option exercises and related sales executed through family trusts. A family trust exercised 9,500 stock options at an exercise price of $135.42 per share, converting them into 9,500 shares of common stock held indirectly.
On the same date, the trust sold a total of 9,500 common shares in multiple open-market transactions at weighted average prices ranging from about $501.06 to $508.17 per share. These trades were made under a pre-arranged Rule 10b5-1 trading plan adopted on November 7, 2025, which continues until the earlier of the exercise of 1,734,410 stock options expiring March 15, 2027, or December 31, 2026. Following the derivative transaction, a family trust continues to hold 122,910 stock options, while reported common stock holdings include 40,513 shares held directly by Rothblatt and 166 shares held indirectly by a spouse, plus additional indirect trust holdings.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
Exercise and Sale: 9,500 shares ($3.53M approx. pre-tax spread)
Exercise and Sale
14 txns
Insider
ROTHBLATT MARTINE A
Role
Chairperson & CEO
Sold
9,500 shs ($4.81M)
Approx. gross sale proceeds
$4.81M
Approx. exercise cost
$1.29M
Approx. pre-tax spread
$3.53M
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option F1, F13 | 9,500 | $0.00 | $0.00 |
| Exercise | Common Stock F1, F2 | 9,500 | $135.42 | $1.29M |
| Sale | Common Stock F1, F3, F2 | 213 | $501.0617 | $107K |
| Sale | Common Stock F1, F4, F2 | 427 | $502.1812 | $214K |
| Sale | Common Stock F1, F5, F2 | 120 | $504.2066 | $61K |
| Sale | Common Stock F1, F6, F2 | 1,238 | $505.3615 | $626K |
| Sale | Common Stock F1, F7, F2 | 2,521 | $506.3508 | $1.28M |
| Sale | Common Stock F1, F8, F2 | 3,298 | $507.4299 | $1.67M |
| Sale | Common Stock F1, F9, F2 | 1,683 | $508.1725 | $855K |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock F10 | -- | -- | -- |
| holding | Common Stock F11 | -- | -- | -- |
| holding | Common Stock F12 | -- | -- | -- |
Holdings After Transaction:
Stock Option — 122,910 shares (Indirect, by Trust);
Common Stock — 628,049 shares (Indirect, by Trust);
Common Stock — 40,513 shares (Direct);
Common Stock — 166 shares (Indirect, by Spouse)
Footnotes (13)
- F1. This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 15, 2027; or (b) December 31, 2026.
- F10. Shares held in family trusts as to which the Reporting Person's spouse is sole trustee and sole beneficiary or co-trustee and settlor with power to revoke.
- F11. Shares held in family trusts as to which the Reporting Person's spouse shares investment power and the Reporting Person and/or immediate family members are beneficiaries.
- F12. Shares held in family trusts as to which the Reporting Person is sole trustee and sole beneficiary or co-trustee and settlor with power to revoke.
- F13. Stock options held in a family trust as to which the Reporting Person shares investment power and the Reporting Person and immediate family members are beneficiaries.
- F2. Shares held in family trusts as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries.
- F3. This transaction was executed in multiple trades at prices ranging from $500.63 to $501.45. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F4. This transaction was executed in multiple trades at prices ranging from $501.66 to $502.27. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F5. This transaction was executed in multiple trades at prices ranging from $503.57 to $504.56. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F6. This transaction was executed in multiple trades at prices ranging from $504.79 to $505.785. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F7. This transaction was executed in multiple trades at prices ranging from $505.82 to $506.80. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F8. This transaction was executed in multiple trades at prices ranging from $506.82 to $507.815. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F9. This transaction was executed in multiple trades at prices ranging from $507.82 to $508.69. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Key Figures
Options exercised: 9,500 shares
Option exercise price: $135.42 per share
Shares sold: 9,500 shares
+5 more
8 metrics
Options exercised
9,500 shares
Stock options exercised by family trust on 2026-08-17
Option exercise price
$135.42 per share
Exercise price of stock options converted into common stock
Shares sold
9,500 shares
Total UTHR common shares sold in multiple trades on 2026-08-17
Sale prices range
$500.63–$508.69 per share
Weighted-average transaction ranges from related sale footnotes F3–F9
Options remaining in trust
122,910 options
Stock options held in a family trust after the reported exercise
Direct common stock holdings
40,513 shares
Common stock held directly by Martine A. Rothblatt after transactions
Spouse-held shares
166 shares
Common stock held indirectly by spouse
10b5-1 plan option pool
1,734,410 options
Maximum stock options to be exercised under current 10b5-1 plan
Key Terms
Rule 10b5-1 trading plan, weighted average price, exercise of stock options, family trusts, +1 more
5 terms
Rule 10b5-1 trading plan regulatory
"This exercise of stock options and sale...was pursuant to a pre-arranged 10b5-1 trading plan"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
weighted average price financial
"The price reported above reflects the weighted average price"
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
exercise of stock options financial
"This exercise of stock options and sale of the resulting shares of common stock"
family trusts financial
"Shares held in family trusts as to which the Reporting Person's spouse is sole trustee"
investment power financial
"Shares held in family trusts as to which the Reporting Person shares investment power"
FAQ
What insider transactions did UTHR CEO Martine Rothblatt report on August 17, 2026?
Rothblatt reported exercising 9,500 stock options at $135.42 per share through a family trust and selling 9,500 common shares in multiple open-market trades at weighted average prices between about $501 and $508 per share.
Were Martine Rothblatt’s UTHR stock transactions under a Rule 10b5-1 plan?
Yes. The option exercise and related sales were made under a pre-arranged Rule 10b5-1 trading plan adopted on November 7, 2025, which remains in effect until certain option exercises are completed or until December 31, 2026.
What UTHR stock options did Martine Rothblatt exercise in this filing?
A family trust exercised 9,500 stock options for UTHR common stock at an exercise price of $135.42 per share. These options were part of a larger pool that, according to the plan terms, all expire on March 15, 2027.
How many UTHR stock options are covered by Martine Rothblatt’s current 10b5-1 plan?
The Rule 10b5-1 trading plan will continue until the earlier of the exercise of 1,734,410 stock options, all expiring on March 15, 2027, or December 31, 2026, according to the footnote disclosure.
AI-generated analysis. How Rhea-AI works. Not financial advice.
